How do I hire a fractional head of revenue for a medical device company in 2027?

Question

Pulse · Accepted Answer

# How do I hire a fractional head of revenue for a medical device company in 2027? ```answer
A fractional head of revenue (fractional CRO) for a medical device company in 2027 will is scoped as a retainer for 10–20 days of monthly engagement, with 0–5% equity in milestone-based vesting. Total annual cash cost ranges from a retainer, versus a retainer plus benefits for a full-time CRO.
``` ## Direct Answer Hiring a fractional head of revenue for a medical device company in 2027 is a strategic decision driven by capital efficiency and the need for specialized go-to-market expertise without a full-time executive commitment. You are looking for someone who understands the complex regulatory sales cycles (FDA clearance, hospital procurement, reimbursement coding) and can build a scalable revenue engine from your current stage. The cost range above reflects the variability in scope: a pre-revenue startup needing 10 days/month of strategic guidance will be at the low end; a Series A company requiring 20 days/month plus hands-on pipeline management, channel partner setup, and board reporting will be at the high end. The key is to find a fractional CRO who has *sold into* the medical device ecosystem, not just adjacent industries like SaaS or medtech software. ```steps
title: How to hire a fractional head of revenue for a medical device company in 2027
- Step 1: Define your stage and revenue gap | Are you pre-revenue, early revenue (<1M), or scaling (1M–10M)? This determines days/month and compensation.
- Step 2: Write a "fractional CRO brief" | Include your product, target hospital/IDN segment, sales cycle length, current team (if any), and what you need: strategy, pipeline, hiring, or all three.
- Step 4: Interview for regulatory fluency | Ask: "How have you navigated hospital GPO contracts?" or "What's your experience with 510(k) clearance sales cycles?" — generic SaaS CROs often fail here.
- Step 5: Check references with previous fractional engagements | Ask: "How did they split time between strategy and execution?" and "What was the biggest miss in their first 90 days?"
- Step 6: Structure a 3-month pilot with clear KPIs | Pipeline velocity, qualified opportunities created, and a documented sales playbook — with a 30-day out clause for either side.
``` ```compare
a: Fractional CRO (10–20 days/month)
b: Full-time CRO (40+ hours/week)
- Cost | a retainer cash + 0–5% equity | 250k–400k base + benefits + 5–10% equity
- Commitment | 3–12 months, renewable | 12–24 months minimum
- Speed to impact | 2–4 weeks ramp | 8–12 weeks ramp (notice period, relocation)
- Best for | Pre-revenue to 5M ARR, capital-efficient scaling | 5M+ ARR with complex sales org needing full-time leadership
- Risk | Low (pilot structure, can replace quickly) | High (severance, cultural disruption)
``` ```callout
type: tip
Medical device revenue cycles are long (9–18 months from first contact to first purchase) and involve multiple stakeholders: surgeons, hospital administrators, GPO committees, and sometimes reimbursement consultants. A fractional CRO who has lived through this will bring ready-made territory plans, channel partner templates, and regulatory messaging that a generic SaaS CRO cannot replicate.
``` ## Why Medical Device Is Different from Other B2B Revenue Leadership Medical device companies face a unique revenue challenge: the buyer is not a single person but a **network of decision-makers** with conflicting priorities. The surgeon wants clinical outcomes, the hospital administrator wants cost containment, the GPO wants compliance, and the reimbursement team wants clear coding. A fractional CRO from a SaaS background will default to "land and expand" or "product-led growth" — both mostly irrelevant here. You need someone who can map a hospital system's **capital equipment budget cycle** (often calendar-year based) and align your sales process to it. In 2027, the regulatory environment has not simplified. FDA 510(k) clearance, CE marking under MDR, and ISO 13485 compliance are table stakes. Your fractional head of revenue must be able to **speak credibly** with your clinical team about how these impact sales messaging — not to replace your regulatory expert, but to ensure the sales deck doesn't promise something the device hasn't been cleared for. This is a common failure point: founders hire a great SaaS CRO who overpromises on clinical claims, triggering compliance risk. ## The Fractional CRO vs. VP of Sales Decision Many founders confuse "fractional head of revenue" with "fractional VP of Sales." They are not the same. A **fractional CRO** owns the entire revenue function: sales, marketing, customer success, channel partnerships, and revenue operations. A **fractional VP of Sales** typically only manages the direct sales team and pipeline. For a medical device company in 2027, you almost always need a fractional CRO because the revenue engine is underdeveloped — you need someone who can build the marketing-qualified lead (MQL)

Kory White

How do I hire a fractional head of revenue for a medical device company in 2027?

Two scores — Gate vs IQ